Hi @suzannebhi,
I completely understand your concerns. It’s a difficult situation, and your reaction is very natural.
In addition to that, Incyte currently has several clinical trials underway, and there are already some promising treatment approaches emerging, which is encouraging.

For many patients, conventional therapy remains the first line to prevent vascular events (thrombosis/hemorrhage).

You might find this paper helpful for more detailed information:
https://www.sciencedirect.com/science/article/abs/pii/S1530891X25009693.